A Critique of SAINT II-Reference-Cited by-同舟云学术

A Critique of SAINT II

Published:2008-04 Issue:4 Volume:39 Page:1389-1391
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Savitz Sean I.¹,Schäbitz Wolf-Rüdiger¹

Affiliation:

1. From the Department of Neurology (S.I.S.), University of Texas Houston Medical School, Houston, Texas; and the Department of Neurology (W.-R.S.), University of Münster, Münster, Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Link

https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.107.504415

Reference11 articles.

1. NXY-059 for the Treatment of Acute Ischemic Stroke

2. NXY-059 for Acute Ischemic Stroke

3. Toward a Multimodal Neuroprotective Treatment of Stroke

4. Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N -Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model

5. Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Modification of Acute Cerebral Ischemia;Stroke;2022

2. From Tumor Metastasis towards Cerebral Ischemia—Extracellular Vesicles as a General Concept of Intercellular Communication Processes;International Journal of Molecular Sciences;2019-11-28

3. Neuroprotectants in the Era of Reperfusion Therapy;Journal of Stroke;2018-05-31

4. The neuroprotective effect of focused ultrasound: New perspectives on an old tool;Brain Research Bulletin;2017-05

5. Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?;CNS & Neurological Disorders - Drug Targets;2016-10-07